Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INO-8875 in ocular hypertension or primary open-angle glaucoma
NCT01123785Phase 2Completed
- Sponsor
- Inotek Pharmaceuticals
- Start
- May 2010
- Primary completion
- Dec 2011
- Countries
- 1
01
Overview
A Phase 2 trial of trabodenoson in ocular hypertension, Primary Open Angle Glaucoma (POAG), sponsored by Inotek Pharmaceuticals. Started May 2010; status: completed.
02
Drugs
trabodenoson
03
Conditions
ocular hypertensionPrimary Open Angle Glaucoma (POAG)
Beyond the preview
Go deeper on NCT01123785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01123785.